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Abstract
BACKGROUND: Fever in neurocritical care patients is common and has a negative impact on
neurological outcome. The purpose of this prospective observational study was (1) to evaluate the
practicability of cooling with newly developed neck pads in the daily setting of neurointensive care unit
(NICU) patients and (2) to evaluate its effectiveness as a surrogate endpoint to indicate the feasibility of
neck cooling as a new method for intractable fever.
METHODS: Nine patients with ten episodes of intractable fever and aneurysmal subarachnoid
hemorrhage were treated with one of two different shapes of specifically adapted cooling neck pads.
Temperature values of the brain, blood, and urinary bladder were taken close meshed after application
of the cooling neck pads up to hour 8.
RESULTS: The brain, blood, and urinary bladder temperatures decreased significantly from hour 0 to a
minimum in hour 5 (P < 0.01). After hour 5, instead of continuous cooling in all the patients, the
temperature of all the three sites remounted.
CONCLUSION: This study showed the practicability of local cooling for intractable fever using the
newly developed neck pads in the daily setting of NICU patients.
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Abstract 
Background and Purpose 
Fever in neurocritical care patients is common and has a negative impact on 
neurological outcome. The purpose of this prospective observational study was 1. to 
evaluate the practicability of cooling with newly developed neck pads in the daily 
setting of neurointensive care unit (NICU) patients and 2. to evaluate its effectiveness 
as a surrogate endpoint to indicate the feasibility of neck cooling as a new method for 
intractable fever. 
Methods 
9 patients with 10 episodes of intractable fever and aneurysmal subarachnoid 
hemorrhage were treated with one of two different shapes of specifically adapted 
cooling neck pads. Temperature values of the brain, blood and urinary bladder were 
taken close meshed after application of the cooling neck pads up to hour 8.  
Results 
The brain, blood and urinary bladder temperatures decreased significantly from hour 
0 to a minimum in hour 5 (p<0.01). After hour 5, instead of continuous cooling, in all 
patients the temperature of all three sites remounted.  
Conclusion 
This study showed the practicability of local cooling for intractable fever using the 
newly developed neck pads in the daily setting of NICU patients.  
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Introduction 
Fever occurs with an incidence of up to 70% in neurologically injured patients. To 
reduce fever-related secondary brain damage and improve clinical outcome the 
temperature of the brain needs to be monitored and strictly controlled [1-7]. One of 
the key centers of thermoregulation of the human body represents the medial 
preoptic anterior hypothalamic area (POA), influenced by multiple thermoreceptors, 
feedforward reflex pathways, feedback mechanisms and pyrogenic mediators [1, 7-
11]. Furthermore, the POA is supplied by dendrites ending in the third ventricle and 
getting information of all ascending thermoreceptive pathways as well as 
endogenous signals in the cerebrospinal fluid [8, 9] (Figure 1). 
There are various possibilities to intervene in this thermoregulation by external 
devices. Compared to an intravascular cooling method, which is efficient and fast, but 
invasive and with several relevant side effects such as venous thrombosis or cause 
of infections, the advantage of a local cooling device becomes obvious. For specific 
cooling of the deep brain, head caps are not efficient [12-14], whereas neck pads 
covering bilateral the carotid triangle decrease the brain temperature in a 
mathematical simulation [13, 15]. In a previous study we simulated cerebral 
temperature behavior by applying different cooling devices [13]. They simulated 
cerebral temperature behavior with hypothermia treatment applying different cooling 
devices. The models were based on hourly temperature values recorded in patients 
with severe aneurysmal subarachnoid hemorrhage (aSAH), taking into account 
magnetic resonance imaging data, thermal conductive properties, metabolism and 
blood flow, and were applied to different scenarios of hypothermia. In summary, 
systemic hypothermia by endovascular cooling lead to a uniform temperature 
decrease within the brain tissue. Cooling with head caps lead to 33C only in the 
superficial brain while the deep brain remains higher than 36C. In contrast cooling 
with neck pads, covering the carotid triangles, lead to 35.8C for dry and 32.8C for 
wet skin in the deep brain within 6 hours. The equation of the mathematical model 
included temperature-dependent blood perfusion, cerebral metabolic rate, and time-
dependent arterial blood temperature [13]. 
These findings encouraged us to create new shapes of cooling devices for selective 
cooling of the carotid triangles in order to attempt to decrease the brain temperature 
in patients with fever resisting conventional methods. The purpose of this 
observational study was to evaluate the practicability of cooling with newly developed 
neck pads in the daily setting of neurointensive care unit (NICU) patients and its 
effectiveness as a surrogate endpoint to indicate the feasibility of neck cooling as a 
new method for intractable fever. 
Methods 
This prospective study was approved by the local ethics committee and followed 
institutional guidelines. 
Two shapes of neck pads for covering the carotid triangles with a contact surface as 
large as possible have been developed. These neck pads were effective in cooling 
the blood inflow within the carotid arteries without limiting the patient care and 
comfort nor venous drainage. The first shape was created for standard-sized necks. 
The second shape of the neck pads was created to fit patients with a short neck or a 
tracheostoma, with a smaller width in general and above all in the middle section 
(Figure 2a, b). Corresponding to our mathematical simulations the heat transfer 
coefficient (htc) in these pads was about 22.4 watts per meter squared-kelvin 
(W/(m2K)) with a mathematical optimal htc of 28 W/(m2K). Tissue density, tissue 
specific heat coefficients, blood perfusion rate, heat source of the natural metabolism 
and further values were implemented in the mathematical equation representing the 
thermal behavior of the different tissues and blood, which was developed in the 
previous study [13] and transferred in this practical observational study. The 
ArcticSun® Temperature Management System (Medivance, Louisville CO) was used, 
employing hydrogel-coated water-circulating energy transfer pads to allow an 
intimate adhesion to the patient’s skin and a similar heat exchange coefficient as in a 
water bath [16]. The cooling system was set to the automatic mode with the desired 
patient target temperature of 36.8°C working continuously with maximal cooling 
capacity. The lowest water temperature was 5°C. The water flow through the neck 
pads was accelerated by a shunt-line parallel to the neck pad flow, resulting in a 
continuous flow between 1.7 l/min and 2.3 l/min.  
Inclusion criteria of our 9 consecutive patients were having a brain temperature probe 
and presenting episodes of intractable fever (n=10) within four weeks after aSAH. 
Patient demographics are summarized in table 1. Our standard treatment protocol of 
patients with aSAH is described by Lerch et al. [17]. Each patient was treated with 
one of the specific neck pads. Intractable fever was defined as a temperature >37.8° 
persistent after 2 hours of expanded standard fever management with application of 
acetaminophen (1 gram every 6 hours), novaminsulfone (1 gram every 6 hours), 
specific washing solutions (mixture of yellow lemon, bergamot, cajeput oil, star 
eucalyptus, added by water) and ice packs (inguinal).  
Overall 459 temperature values of the brain (Tbrain), blood (Tblood) and urinary 
bladder (Tbladder) were taken every 15 minutes over a period of 2 hours, every 30 
minutes until hour 4 and hourly up to hour 8, after application of the cooling neck 
pads. Tbrain was continuously recorded via a thermistor embedded in the ventricular 
drainage (Neurovent-P Temp, Raumedic®), in addition to continuous temperature 
measurement of the arterial blood (Pulsiocath Thermodilution catheter, Pulsion 
Medical Systems AG) and the urinary bladder via indwelling catheter (Foley Catheter 
with temperature sensor, Curity, Kendall, tyco Healthcare). 
Patients with remounting temperatures after the 8 hours of applied neck pads were 
treated either by adding leg or body pads of the ArcticSun® system or by placing an 
intravascular cooling system. 
All patients were monitored carefully for possible side effects related to the 
application of the neck pads. Side effects were defined as skin irritation, pressure 
marks, wound infection, disturbances in wound healing of a new tracheostomy or 
shivering. Shivering, defined as involuntary, oscillatory muscular activity and 
cutaneous vasoconstriction [18] was assessed together with each taken temperature 
value at fixed times as mentioned above and documented as absent, mild, or severe.  
Changes of the analgetic or sedative medication, changes in arterial blood pressure 
and heart rate were documented at least hourly following the standard treatment 
protocol. 
Temperature values are given in mean °C ± standard deviation. All temperature 
values of the 3 compartments before and after cooling, as well as the temperature 
values between brain, blood and urinary bladder were compared using a paired 
Wilcoxon Mann-Whitney U – test.  
Results 
The brain temperature decreased significantly after 5 hours with neck pad cooling 
from 38.2±0.3 (hour 0) to a minimum of 37.7±0.3 (hour 5) (p<0.01). Comparably 
Tblood and Tbladder decreased significantly from hour 0 to a minimum in hour 5 from 
38.1±0.3 to 37.7±0.2 and from 38.3±0.4 to 37.8±0.3, respectively (p<0.01). After hour 
5, instead of continuous cooling, in all patients the temperature of the brain 
remounted (Figure 3).  
The cooling system was set to the automatic mode maintaining 5°C after 
achievement of steady-state status during the study period in all patients. 
In eight fever episodes of seven patients the performed standard methods in fix 
intervals for lowering temperature (see above) were continued during the neck pad 
application without any systematic lasting decline in temperature (38.1±0.4 before 
medicaments (n=8) or washing (n=4), respectively and 38.0±0.3 after one hour of 
one of these interventions; (n=12)). 
No shivering and no side effects as defined above related to the neck pad cooling 
technique occurred. Furthermore, no increase of ICP as a potential worsening of 
jugular venous drainage occurred, no related changes in blood pressure or heart rate 
were observed, and a tracheostoma was not debilitating. The analgosedation of the 
patients ranged between deep comatose and awake with slight analgosedation (table 
1). No change of analgosedation was performed during the study period. 
Discussion 
Choosing patients with aneurysmal subarachnoid hemorrhage, provides a group of 
patients at high risk for fever, who are most difficult to treat [1]. After application of 
various antipyretics and cool washing solutions the neck pads could significantly 
decrease the temperature of the brain, blood and urinary bladder, respectively. 
Although the cooling result was significant, the amount of temperature decrease was 
small. We studied 9 consecutive patients with intractable fever with random neck 
sizes and created two shapes of neck pad devices, in order to achieve a more 
flexible fit to the various neck types. The neck pads were applicable in every neck 
constitution of our patients.  
We observed no side effects and no shivering as defined in the method section. 
Possible explanations for the lack of shivering in our patient group might be the small 
covered area by the neck pads, the small amount of temperature decline and 
analgosedation in most of the patients. Furthermore, in all our patients serum 
magnesium levels were close to the upper limit [18], following our standard treatment 
protocol of aSAH [17]. Despite concerns of an accidental obstruction of the jugular 
venous drainage or triggering of autonomous dysfunctions via vulnerable structures 
like the glossopharyngeal and vagal nerves or carotid bodies, we did not observe any 
relevant changes concerning these issues during the study period after application of 
the neck pads. Applying the neck pads as local cooling devices, one should keep in 
mind that it seems to present not only local but also systemic hypothermic effects. 
This could also be assumed by our results of simultaneous behavior of the 
temperatures in all three locations (brain, urinary bladder, blood) and might be 
associated with systemic side effects.   
Illustrated in Figure 3, there are two episodes of remounting temperatures. Regarding 
the short-term temperature increase in our patients after the same delay time after 
the start of the neck pad device application, spontaneous fever variations seem to be 
unlikely. The hypothesis of a counterregulation provoked by treatment of fever was 
discussed by Keller et al. [13] based on the mathematical models. The origin and 
mechanisms of thermoregulation of brain and body are very complex and the exact 
causes of set-point changes are discussed controversially [19-21]. Performing a kind 
of interval cooling to avoid or reduce triggering of potential counterregulation could be 
an alternative approach in order to attempt to extend the period of normalized brain 
temperature. But it would be very difficult to define the most efficient on-/off-time 
episodes for cooling, as well as the consideration of all the unstable components. To 
the best of our knowledge, there is no mathematical model to simulate the reaction of 
fever treatment and counterregulation. In 8 of 10 fever episodes the patients received 
additional applications to the cooling neck pads, such as acetaminophen, 
novaminsulfone or specific washing, independently of the first early remount of 
temperature. The antipyretics were given in standardized fixed intervals and 
continued as analgetic drugs when it came to the decision to apply the neck pads. 
We inspected the temperature values across the whole range during each of the 12 
washing and pharmacological interventions and compared it with the following data 
points without observing a marked effect. A circadian rhythm of body temperature 
with 12 hours between lowest and peak temperature seems not to be relevant in our 
study period of 8 hours and shorter segments of remounting temperatures. 
In contrast to other studies [12, 20, 22], the brain temperature in our evaluation was 
not consistently higher than in the arterial blood or in the urinary bladder. 
Nevertheless, monitoring of the brain temperature with thermistors in the ventricular 
system or in the deep brain parenchyma (at least 2 cm below the cortical surface 
[13]) is essential to study the effectiveness of new devices for selective cerebral 
cooling.  
Because of the description of the higher temperature in any brain structure than in 
the rest of the body, as well as the faster and more obvious changes of temperature 
in the brain [22, 23], there is a necessity to use specific devices to cool especially the 
brain. An increase in blood temperature would heat the well-perfused brain rapidly, 
and a decrease in blood temperature would lead to a rapid decrease of the brain 
temperature, respectively [23]. As shown in other studies selective brain cooling with 
a cap is not sufficient, for which reason the future selective cooling devices should be 
restricted to cooling the arterial flow of the neck [13, 15, 24, 25].  
The idea to develop new devices for selective neuroprotective cooling of the brain 
parenchyma has already been published [12, 26-32]. In each of the studies the 
device became more specific and smaller [33]. Future improvements of the local 
cooling system must be performed with the intention to improve the material 
properties of the neck pads concerning the contact surface and the heat transfer 
coefficients. 
Limitations 
Concerning this new neck pad device several limitations have to be discussed. We 
studied 9 consecutive patients without classifying the neck type in slim, thick and 
short necks. The study is limited by only a small number of patients and fever 
episodes and no control group. No extended monitoring values such as CO2, detailed 
changes of heart rate, blood pressure or respiration were taken into account in this 
first evaluation study. Having small temperature decreases and continuing standard 
fever treatment in a small patient group makes it difficult to differentiate between the 
definitive effect of the neck pads and spontaneous fever curve.  
In future studies with an optimized neck pad and a larger number of patients, 
including a control group, a differentiation between different neck sizes is 
recommended. 
Conclusion 
This study showed the practicability of local cooling for intractable fever using the 
newly developed neck pads in the daily setting of NICU patients.  
Representing the first observational study without the use of a control group, it is not 
possible to determine if selective cooling of the neck with these pads might be 
efficient in decreasing intractable fever and sustaining normothermia over a 
prolonged period.  
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Figure captions 
 
Figure 1 
Simplified cascade of thermoregulatory pathways. 
 
Figure 2 a, b 
Cooling neck pads with afferent and efferent suction of cool water from the right side. 
a: regular shape 
b: shape for short necks and/or tracheostoma 
 
Figure 3 
Three diagrams showing the data of all temperatures (T in °C) taken in the blood, 
brain or urinary bladder over a period of 8 hours after application of the neck pad 
device, with shorter time intervals at the beginning. 
Bold black line and bars: 
Bold line represents the mean of the temperatures, the bars demonstrate the mean ± 
standard deviation from hour 0 (before application of the neck pad cooling) to hour 8 
(after start of the neck pad cooling). 
Fine lines: 
Each fine blue line represents one fever episode with each registered value before 
(hour 0) and after application of the neck pad (until hour 8). The red line represents 
the median. 
Numbers above each diagram from the left to the right:  
Mean hour 0 and standard deviation 
Mean hour 5 and standard deviation 
Table 1 
 
Patient demographics  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Female 4 
Male 5 
Age (years) 48.7  9 
Hunt & Hess 
Fisher Grade 
WFNS 
3.3   1.0 
3.4   0.5 
3.2   1.6 
Clipping 
Coiling 
4 
5 
Fever post-SAH (days) 8.3  5.9 
Infection 
Central fever 
8 
2 
Vigilance on “neck pad day”: 
GCS  13 
Comatose 
 
1 
8 
Analgosedation 
Fentanyl 
Midazolam 
Thiopental 
Propofol 
7 
5 
5 
1 
2 
Spontaneous breathing 
Artificial ventilation 
Oral intubation 
Tracheostoma 
2 
7 
5 
3 




